Tecan Group AGLTS:0QLN -0.63%73 OCF Margin % is 17.61% as of Dec. 2025, which is 12% above its 10-year median of 15.77. GuruFocus rates LTS:0QLN with a GF Score™ of 73/100 and a GF Value™ of CHF244.11 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Tecan Group AG ranks better than 70.13% on this metric.
The historical rank and industry rank for Tecan Group AG's OCF Margin % or its related term are showing as below:
LTS:0QLN'
s OCF Margin % Range Over the Past 10 Years
Min: 11.21 Med: 15.77 Max: 28.5
Current: 15.64
During the past 13 years, the highest OCF Margin % of Tecan Group AG was 28.50%. The lowest was 11.21%. And the median was 15.77%.
LTS:0QLN's OCF Margin % is ranked better than 70.13% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs LTS:0QLN: 15.64
Tecan Group AG OCF Margin % Related Terms
Tecan Group AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLN vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Tecan Group AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (LTS:0QLN) has a OCF Margin % of 17.61% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Tecan Group AG and its competitors. This is 12% above median its historical median of 15.77. Over the past decade, Tecan Group AG's OCF Margin % has ranged from 11.21 to 28.50. According to the industry distribution chart, Tecan Group AG ranks #244 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Tecan Group AG's OCF Margin % too high?
Tecan Group AG's current OCF Margin % of 17.61% is 12% above median its 10-year median of 15.77. Over the past 10 years, this metric has ranged from a low of 11.21 to a high of 28.50. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Tecan Group AG's value of 17.61% is 202.6% above this industry median. Based on the distribution chart, Tecan Group AG ranks #244 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tecan Group AG has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #244 out of 817 companies for OCF Margin %. This puts Tecan Group AG in the upper half of its industry. The industry median OCF Margin % is 5.82. Tecan Group AG's value of 17.61% is 202.6% above this benchmark. Historically, Tecan Group AG's own OCF Margin % has ranged from 11.21 to 28.50 over the past decade. While the company's 10-year median is 15.77 vs. the industry median of 5.82, Tecan Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tecan Group AG's current OCF Margin % of 17.61% is 202.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Tecan Group AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current OCF Margin % is 17.61%, which is 12% above median its own 10-year median of 15.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (LTS:0QLN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF244.11, compared to a current price of CHF176.73 — trading 27.6% below its estimated fair value. The current OCF Margin % is 17.61%, which is 12% above median its 10-year median of 15.77 and 202.6% above the Medical Devices & Instruments industry median of 5.82. Tecan Group AG's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Tecan Group AG (LTS:0QLN), the current OCF Margin % is 17.61% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (LTS:0QLN) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued.
The current stock price of CHF176.73 is trading 27.6% below its estimated GF Value™ of CHF244.11.
GuruFocus considers Tecan Group AG to be Modestly Undervalued.
Key valuation signals for LTS:0QLN:
OCF Margin %: 17.61% (12% above median its 10-year median of 15.77)
GF Value™: CHF244.11 vs. price of CHF176.73 (27.6% below fair value)
Industry Position: 202.6% above the Medical Devices & Instruments median (#244 of 817)
No single metric tells the full story. See the LTS:0QLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
73GF Score
Get the complete analysis for LTS:0QLN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLN has been successfully added to your 
